Literature DB >> 12591161

Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures.

K A Lehtimäki1, J Peltola, E Koskikallio, T Keränen, J Honkaniemi.   

Abstract

We have previously shown that IL-6 protein levels are increased in cerebrospinal fluid in humans after recent tonic-clonic seizures with unchanged levels of IL-1beta and TNFalpha. Here we studied the expression of cytokines IL-6, LIF, IL-1beta and TNFalpha and cytokine receptors IL-6R, LIFR and Gp130 in the rat brain after kainic acid-induced status epilepticus using Northern blot analysis and in situ hybridization histochemistry. After seizures, IL-6 mRNA was induced in the hippocampus, cortex, amygdala and meninges, and IL-6R was up-regulated in the hippocampus. LIF was up-regulated in the hippocampus, cortex and meninges after seizures, and LIFR mRNA was induced in the hippocampus and cortex. Gp130 was constitutively expressed in the brain. After seizures, Gp130 transcription was rapidly induced in the meninges. In thalamus, cortex, amygdala and hippocampus Gp130 mRNA was induced in a delayed fashion. IL-1beta transcription was induced in the temporal lobe cortex and thalamus, and TNFalpha in the hippocampus. In general, the cytokine and their receptor mRNA levels were low in intact rat brain, but were induced by seizures. Since IL-6 and LIF transcripts were induced in the meninges after seizures, the protein products of these transcripts may be more readily released in cerebrospinal fluid after seizures. In addition, the activity of IL-6 and LIF signaling pathways may be influenced by increased expression of their receptors after seizures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591161     DOI: 10.1016/s0169-328x(02)00654-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  35 in total

1.  Regulation of kindling epileptogenesis by hippocampal Toll-like receptors 2.

Authors:  Jesús-Servando Medel-Matus; Ashley Reynolds; Don Shin; Raman Sankar; Andrey Mazarati
Journal:  Epilepsia       Date:  2017-06-20       Impact factor: 5.864

2.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

3.  Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation.

Authors:  Pallavi B McElroy; Li-Ping Liang; Brian J Day; Manisha Patel
Journal:  Exp Neurol       Date:  2017-08-16       Impact factor: 5.330

4.  Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6.

Authors:  T E Nelson; A Olde Engberink; R Hernandez; A Puro; S Huitron-Resendiz; C Hao; P N E De Graan; D L Gruol
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

5.  Opposing effects of proteasomes and lysosomes on LIFR: modulation by TNF.

Authors:  Chuanhui Yu; Abba J Kastin; Hong Tu; Weihong Pan
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 6.  Immune-neural connections: how the immune system's response to infectious agents influences behavior.

Authors:  Robert H McCusker; Keith W Kelley
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

7.  Alpha-MSH rescues neurons from excitotoxic cell death.

Authors:  Asa Forslin Aronsson; Stefan Spulber; Mircea Oprica; Bengt Winblad; Claes Post; Marianne Schultzberg
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

8.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

9.  Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Authors:  Snjezana Zaja-Milatovic; Ramesh C Gupta; Michael Aschner; Dejan Milatovic
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

Review 10.  Causes of CNS inflammation and potential targets for anticonvulsants.

Authors:  Mercé Falip; Xavier Salas-Puig; Carlos Cara
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.